维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Dizon DS"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Chemotherapy in women with advanced ovarian cancer 显示文摘	Gordinier ME Dizon DS Weitzen S	2007	Palliat Med2007，10，1：	1
2	Retrospective analysis of carboplatin and paclitaxel as initial second-line-therapy for recurrent epithelial ovarian carcinoma:Application toward a dynamic disease state model of ovarian cancer显示文摘	Dizon DS Hensley ML Poynor EA	2002	J Clin Oncol2002，20，5：	1
3	Oral thalidomide as pal- liative chemotherapy in women with advanced ovarian cancer显示文摘	Gordinier ME Dizon DS Weitzen S	2007	J Palliative Med2007，10，1：	1
4	Chemotherapy toxicity in gynecologic cancer patients with a body surface area(BSA)>2m 2显示文摘	Schwartz J Toste B Dizon DS	2009	Gynecologic Oncology2009，114，1：	1
5	Two for good measure:six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer显示文摘	Dizon DS Weitzen S Rojan A	2006	Gynecol Oncol2006，100，2：	1
6	Medical therapy of endometriat cancer:CmTent status and promising novel treatments 显示文摘	Hill EK Dizon DS	2012	Drugs2012，72，5：	1
7	Cerebral perfusion pressure and not cerebral blood flow may be the critical determinant of intracranial injury in preeclamp sia:a new hypothesis显示文摘	Belfort MA Varner MW Dizon DS	2002	Am Obstet Gynecol2002，187，3：	1
8	Strategies for molecularly enhanced chemotherapy to achieve synthetic lethality in endometrial tumors with mutant p53 显示文摘	Meng X Dizon DS Yang S	2013	Obstet Gynecol Int2013，2013，82：	1
9	Cerebral perfusion pressure and not cerebral blood flow may be the critical determ inant of in tracranial in jury in preeclam psia a new hypothesis显示文摘	Belforl MA Vamer MW Dizon DS		0，，03：	1
10	Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma:application toward a dynamic disease state model of ovarian cancer显示文摘	Dizon DS Hensley ML Poynor EA	2002	J Clin Oncol2002，20，5：	1
11	A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies 显示文摘	Aghajanian C Soignet S Dizon DS	2002	Clin Cancer Res2002，8，8：	1
12	Phase Ⅱ study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first - line chemotherapy for advanced Mtilleriantumors 显示文摘	Penson RT Dizon DS Cannistra SA	2010	J Clin Oncol2010，28，1：	1
13	Dyspnea during thalidomide treatment for advanced ovarian cancer显示文摘	Gordinier ME Dizon DS	2005	Ann Pharmacother2005，39，：	1
14	Quality of life after breast cancer: survivorship andsexuality显示文摘	Dizon DS	2009	Breast J2009，15，：	1
15	A phase Ⅰ trial of the novel proteasome inhibitor PS-341 in advanced solid tumor malignancies显示文摘	Aghajanian C Soignet S Dizon DS	2002	Clin Cancer Res2002，8，4：	1
16	Phase II study of car-boplatin,paclitaxel,and bevacizumab with maintenance beva-cizumab as first-line chemotherapy for advanced mullerian tumors显示文摘	Penson RT Dizon DS Cannistra SA	2010	J Clin Oncol2010，28，1：	1
17	Chemotherapy toxicity in gynecologic cancer patients with a body surface area>2 m显示文摘	Schwartz J Toste B Dizon DS	2009	Gynecol Oncol2009，114，1：	1
18	Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin显示文摘	Gordinier ME Dizon DS Flening EL	2006	Gynecologic Oncology2006，103，1：	1
19	For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? 显示文摘	Dizon DS Restivo A Lomme M	2008	Am J Clin Oncol2008，31，1：	1
20	A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persis- tent platinum-resistant ovarian, fallopian tube, or primary perito- neal carcinoma: a gynecologic oncology group study 显示文摘	Dizon DS Blessing JA Penson RT	2012	Gynecol Oncol2012，125，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示